Panagora Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,831
Closed -$152K 2602
2021
Q2
$152K Buy
6,831
+6,397
+1,474% +$136K ﹤0.01% 1732
2021
Q1
$11K Buy
+434
New +$10.3K ﹤0.01% 2392
2019
Q3
Sell
-15,144
Closed -$180K 2688
2019
Q2
$180K Hold
15,144
﹤0.01% 1826
2019
Q1
$267K Buy
+15,144
New +$252K ﹤0.01% 1610
2017
Q1
Sell
-1,724
Closed -$31K 2467
2016
Q4
$31K Sell
1,724
-105,036
-98% -$1.85M ﹤0.01% 2156
2016
Q3
$2.06M Sell
106,760
-41,624
-28% -$815K 0.01% 891
2016
Q2
$2.89M Sell
148,384
-14,450
-9% -$283K 0.01% 732
2016
Q1
$3.36M Sell
162,834
-17,928
-10% -$353K 0.02% 692
2015
Q4
$3.71M Buy
180,762
+101,169
+127% +$1.94M 0.02% 628
2015
Q3
$1.36M Buy
79,593
+36,502
+85% +$667K 0.01% 907
2015
Q2
$803K Buy
43,091
+29,899
+227% +$554K ﹤0.01% 1182
2015
Q1
$252K Buy
+13,192
New +$244K ﹤0.01% 1581
2014
Q4
Sell
-34,419
Closed -$609K 2362
2014
Q3
$609K Sell
34,419
-118,646
-78% -$2.33M ﹤0.01% 1241
2014
Q2
$3.16M Sell
153,065
-89,302
-37% -$1.84M 0.02% 669
2014
Q1
$5.28M Buy
242,367
+71,433
+42% +$1.64M 0.02% 529
2013
Q4
$4.54M Buy
+170,934
New +$4.2M 0.02% 568

Other funds holding VIVO

Panagora Asset Management's VIVO Position: Q3 2021 in Review

Panagora Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 6,831 shares — an estimated $152K sold.

Panagora Asset Management first reported a position in VIVO in Q4 2013 and held it in 16 quarters. The position peaked at $5.28M in Q1 2014. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • Panagora Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 6,831 Meridian Bioscience Inc shares in Q3 2021, an estimated $152K.
  • Panagora Asset Management first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 16 quarters.
  • Panagora Asset Management's Meridian Bioscience Inc position peaked at $5.28M in Q1 2014.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.